Variant report
Variant | esv3354343 |
---|---|
Chromosome Location | chr2:34922648-34926846 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MAX | chr2:34924385-34924462 | NB4 | blood: | n/a | chr2:34924443-34924453 |
2 | POLR2A | chr2:34926074-34926204 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000272027 | TF binding region |
ENSG00000228262 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560608931 | chr2:34922673-34922674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574176535 | chr2:34922674-34922675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115628161 | chr2:34922699-34922700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372200812 | chr2:34922705-34922706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562686386 | chr2:34922739-34922740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531368971 | chr2:34922748-34922749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142672839 | chr2:34922762-34922763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147355434 | chr2:34922766-34922767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139501003 | chr2:34922798-34922799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544212071 | chr2:34922801-34922802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562320528 | chr2:34922804-34922805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577324198 | chr2:34922817-34922818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527330025 | chr2:34922836-34922837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113128204 | chr2:34922840-34922841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182838439 | chr2:34922846-34922847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529782377 | chr2:34922851-34922852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549577907 | chr2:34922869-34922870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569457365 | chr2:34922931-34922932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538007823 | chr2:34922934-34922935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558498249 | chr2:34922936-34922937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571961041 | chr2:34922938-34922939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185664517 | chr2:34922951-34922952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554185184 | chr2:34922969-34922970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13011970 | chr2:34922973-34922974 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs13012333 | chr2:34922979-34922980 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs13011806 | chr2:34922991-34922992 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs112255977 | chr2:34922992-34922993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6751154 | chr2:34923003-34923004 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs544832937 | chr2:34923014-34923015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190085173 | chr2:34923026-34923027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs564886243 | chr2:34923040-34923041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs527562514 | chr2:34923050-34923051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540661883 | chr2:34923055-34923056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148659703 | chr2:34923081-34923082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183441106 | chr2:34923108-34923109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142173603 | chr2:34923115-34923116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549852768 | chr2:34923131-34923132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569609776 | chr2:34923132-34923133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs188555175 | chr2:34923146-34923147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs550152097 | chr2:34923172-34923173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571507638 | chr2:34923207-34923208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs193115554 | chr2:34923219-34923220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534479677 | chr2:34923257-34923258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs6739366 | chr2:34923268-34923269 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs6754405 | chr2:34923293-34923294 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs372937308 | chr2:34923296-34923297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556625524 | chr2:34923299-34923300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34653060 | chr2:34923310-34923311 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs373771463 | chr2:34923321-34923322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143544474 | chr2:34923329-34923330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:34919600-34926000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr2:34926000-34926400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr2:34926000-34926400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr2:34926200-34926600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr2:34926400-34927800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr2:34926400-34957600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr2:34926600-34927800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |